Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Why Are Cryptos Down Today? 7 Things to Know About the Suex.io Blacklist

Investors asking the question, "Why are cryptos down today?" certainly have a big catalyst to look at, as the government places sanctions.

What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors

Today, NanoViricides is grabbing a lot of attention due to a news pending halt that has sent NNVC stock skyrocketing.

TOST Stock IPO: When Does Toast Go Public? What Is the Toast IPO Price Range?

Among the newest initial public offerings set to take place this week is software company Toast, which will be listed as TOST stock shortly.

ARBK Stock IPO: When Does Argo Blockchain Go Public? What Is the Argo Blockchain IPO Price Range?

Over-the-counter crypto investors are likely excited by the upcoming Argo Blockchain IPO which will launch ARBK stock onto the Nasdaq Exchange.

EDSA Stock: The Covid-19 News Sending Edesa Biotech Soaring on Monday

Today, the announcement of positive clinical trial results has sent investors in Edesa Biotech and EDSA stock on a nice ride.